BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Elektrofi, Inc., a biopharmaceutical formulation technology company focused on transforming the delivery of biologic therapies through strategic partnerships, ...

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for ...

Investing in formulation strategies earlier on in development will maximize the chance of success. The bio/pharmaceutical industry is under more pressure than other industries to create innovative ...

BOSTON--(BUSINESS WIRE)--Elektrofi, a Boston-based biotechnology company focused on drug formulation and delivery innovations, today announced it has entered into an evaluation agreement with Takeda ...

More complex and challenging compounds require a more tailored approach to formulation strategies. Increasingly challenging and complex molecules entering the development pipeline are changing the way ...

To win at the drug development game, it’s not enough to show up with a great molecule. Many compounds would stall at the discovery stage without effective ways to get them inside patients. But the ...

Leukocare is a privately owned, product-focused, clinical-stage biotechnology company founded in 2003 and headquartered in Martinsried/Munich, Germany. The company has been funded since its ...

Formycon will offer liquid, freeze-dried, liposomal, and specialty formulation expertise. German firm Scil Technology established an independent unit, formycon, to provide services for protein drug ...

Pernix announced the launch of a new formulation of Zohydro ER (hydrocodone bitartrate extended-release capsules) with BeadTek, a new abuse-deterrent technology. The new formulation included BeadTek, ...